Restitution Order in Alleged Pill Restocking Case
Last week, according to WZZM13, a federal judge handed down an order for restitution in a case that has already let to more than a dozen arrests. WZZM reports that, according to this ruling, the drug restocking scheme cost Medicare over $64 million and cost Medicaid $18.2 million with an additional $4.7 million lost by Blue Cross Blue Shield of Michigan. The ruling decrees that the CEO and six others must collectively pay $8.8 million, 10% of the total amount lost by public and private insurers due to the fraud.
Citing Judge Jonker’s decision handing down one of many prison sentences in the case, the DOJ reports that the scheme (quoting the press release which internally quotes the ruling) “’created a culture of chaos’ that ‘created real dangers associated’ with cross-contamination and generally taking controlled substances out of the traceable regulatory schemes. Judge Jonker concluded that ‘this was fraud, pure and simple, from the top’ and ‘perpetrated by a person with a history of fraud.’” An FDA official vows: “We will continue to pursue and bring to justice those who would put the public’s health at risk by compromising the prescription drug supply chain.”
Forms of Pharmacy Fraud
Pill restocking is just one form of pharmaceutical fraud. In 2008, the Pharmaceutical Care Management Association (PCMA), an association of professionals who administer prescription drug plans, released a report titled “Finding the ‘Bad Apples’: Case Studies of Pharmacy Fraud, Waste, and Abuse.” The report details several forms of fraud (with examples) including:
- Forgery of prescriptions and price/quantity frauds;
- “Pop Up Pharmacy” scams (ex. billing by an understocked ‘pharmacy’ with irregular hours and patients who said they never patronized the business);
- Failure to dispense prescriptions after billing;
- Sale of returned medications and sample packs;
- “Phantom prescriptions” (ex. pharmacist billed for prescriptions that were neither written nor filled;
- Diversion of (fraudulently prescribed) drugs for illicit sale/use
- False high dollar claims (ex. submitting falsified records showing need for high dollar medications and falsifying satisfaction of eligibility requirements)
Pharmacy fraud is costly and dangerous. When pharmacy fraud involves Medicare, Medicaid, Tricare, or other government benefit programs, it may be a violation of the False Claims Act (“FCA”). The FCA allows private citizens to act as watchdogs and whistleblowers, filing claims on the government’s behalf against perpetrators to bring an end to fraud and force the scammers to return money to the government. Where the whistleblower’s suit leads to a recovery of funds via settlement or verdict, the whistleblower is entitled to a share of the recovery as a reward for their efforts. The amount of the reward can be from 15% to 30%, depending in part on whether the government eventually intervenes in the case or whether the citizen and the whistleblower’s attorney lead the case throughout.
Contact Our Pharmacy Fraud Law Office
If you have witnessed or suspect pharmaceutical fraud, please contact our pharmaceutical fraud lawyer to learn how he can help you be part of the fight against health care fraud. Call (800) 427-7020 or submit the electronic contact form on this page.
See Related Blog Posts:
Off-Label Marketing – Using the False Claims Act to Fight Improper Drug Promotion
Health Care Fraud Spotlight: Kickbacks and Other Fraud in Nursing Home Pharmacy Services
(Image of $$Pill by Bill David Brooks; Image of pill bottle by Pam Roth)